CheMondis logo

CheMondis

CheMondis is the world's smartest chemical platform to find, verify, and interact with new suppliers.

30 employees · est. 2018 · Cologne, Germany

VS
Protagonist Therapeutics logo

Protagonist Therapeutics

Develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies

156 employees · est. 2006 · Newark, United States

Protagonist Therapeutics is the older company (2018 vs 2006); Protagonist Therapeutics is the larger of the two.

Side-by-Side Comparison

CheMondis Protagonist Therapeutics
Founded
2018 2006 older
Headquarters
Cologne, Germany Newark, United States
Employees
30 156 larger
Industry
E-Commerce, Marketplaces Biotechnology, Health Care
Funding Stage
Seed IPO
Total Funding
Not tracked yet $537.50M
Funding Rounds
1 12
Services
online marketplace for chemicals, facilitating supply-demand matchmaking, providing market insights and analytics, digital procurement solutions Not tracked yet
Target Customers
chemical manufacturers, industrial buyers, suppliers seeking visibility, procurement teams in chemical industries Not tracked yet
Taxonomy
B2B Marketplace, Chemical Industry, Chemical Procurement, Supplier Verification, Strategic Procurement, Chemical Sourcing, Data-Driven Decisions, Specialty Chemicals, Base Chemicals, Food Ingredients, Feed Ingredients, Supplier Management, Digital Transformation, Compliance Information Not tracked yet
Website
chemondis.com protagonist-inc.com
CheMondis logo

About CheMondis

CheMondis, founded in 2018, operates out of Germany in the E-Commerce and Marketplaces sectors. The company claims to be the "world's smartest chemical platform," specializing in connecting businesses with verified chemical suppliers globally. With a robust database of qualified suppliers and detail...

Protagonist Therapeutics logo

About Protagonist Therapeutics

Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical n...

We will tell you when either one moves

BounceWatch watches CheMondis and Protagonist Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CheMondis and Protagonist Therapeuti... — by email.

Frequently Asked Questions

CheMondis — CheMondis is the world's smartest chemical platform to find, verify, and interact with new suppliers.. Protagonist Therapeutics — Develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CheMondis has raised undisclosed funding while Protagonist Therapeutics has raised $537.50M.
CheMondis and Protagonist Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CheMondis with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CheMondis on 1 Apr 2026, and Protagonist Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy